Liver Function Flashcards

1
Q

Functions of liver

A

Nitrogen excretion
Protein biosynthesis: aIbumin, etc.
Drugs & alcohol metabolism
Bile formation: composed of phospholipids, bilirubin, bile salts & cholesterol. Digests & absorbs fats.

Liver recieves 70% of blood from portal vein, which supplies it with metabolic substrates first so that liver can detoxify any toxins or pathogens that may be ingested.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bilirubin transport

A

Hb broken down in spleen.
Bilirubin transported to liver bound to albumin.
Becomes conjugated in liver and transported to large intestine.
Converted to urobilinogen, then urobilin, then excreted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Jaundice

A

Abnormally high bilirubin >21PMol/L.
Excess urobilinogen leaves large intestine and enters kidney via portal vein.
Excreted in urine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Prehepatic Jaundice

A

A condition that causes elevated unconjugated bilirubin in blood.
Doesn’t primarily involve the liver but affects it indirectly.
Use Erlich’s reagent to detect urobilinogen in urine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hepatocellular damage

A

Direct damage to liver.
Caused by: viruses (Hepatitis A, B & C), poisons & drugs, alcohol, conditions like non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH).
NAFLD: fatty liver without inflammation & fibrosis.
NASH: fatty liver with inflammation & fibrosis.
Can lead to cirrhosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cirrhosis

A

Long-term damage causes scarring of liver.
Portal blood flow blocked.
Causes cell death & lack of regeneration.
Cirrhotic liver has nodular surface and yellow/green colour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alanine aminotransferase

A

Levels increase sharply when liver is damaged, but low normally.
Although highest activity is in liver, also present in other tissues (cardiac & skeletal muscle).
Can be increased in myocardial infarction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aspartate aminotransferase

A

Levels increase in liver disease, but less than ALT.
Not specific as found in other tissues (cardiac, skeletal, kidney).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Gamma glutamyl transferase

A

Primarily found in liver & biliary tract, and in lower levels in kidneys, pancreas & heart.
Levels increase in most diseases that result in damage to liver or bile products, so not specific.
Normally concentration is low, but increases quickly after liver damage.
Enzyme-inducing drugs (e.g., phenytoin, carbamazepine) and alcohol increase GGT levels.
Good marker for hepatocellular damage & cirrhosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Albumin

A

Exclusively produced by liver, so shows livers ability to synthesise proteins.
Several functions include maintenance of oncotic pressure & transport of bilirubin, hormones & drugs.
Low levels indicate chronic liver dysfunction.
Low levels could also be caused by malnutrition, inflammation, and conditions that cause protein loss by kidneys.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Test for Hep B infection

A

Hep B antigens increase after 1 and a 1/2 months after infection.
Damage is already occuring.
ALT increase after 1 and a 1/2 months.
Use ELISA to detect HepB surface antigen.
Use PCR test to detect viral DNA.
Detects trace amounts of DNA early on in infection.
Amplify & fluorescently tag target gene.
Correlate amount of fluorescence to infection stage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Non-biochemical tests for liver

A

Biopsy to confirm cirrhosis.
Ultrasound to confirm fatty liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cholestatic liver disease

A

Reduced bile flow caused by impaired secretion from hepatocytes or obstruction within the bile ducts.
Can be caused by obstruction (gallstones or pancreatic carcinoma), drugs, primary biliary cirrhosis (chronic autoimmune condition where bile duct is attacked by immune system, preventing bile secretion) or primary sclerosing cholangitis (where bile duct becomes inflamed, thickened, scarred and obstructed).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alkaline phosphatase (ALP)

A

Functions in intestinal homeostasis & protection, by dephosphorylating toxins and inflammatory microbiome ligands.
Although it’s concentrated in liver & bile duct, it’s present in all tissues, including bone, placenta & kidney.
Increased ALP levels can occur due to any obstruction of bile ducts but can also arise due to bone disease.
Autoanalysers detect the total ALP levels without differentiating the various isoforms. Thus, the liver -specific isoform levels cannot be measured.
Requires specialised techniques, including electrophoresis and isoenzyme-specific assays.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bilirubin in cholestatic liver disease

A

Due to obstruction of bile duct, conjugated bilirubin accumulates in liver.
As conjugated bilirubin is water soluble, it’s filtered into urine.
Use a dipstick test to detect bilirubin in urine.
If obstruction continues to occur, bacteria in large intestine can’t ferment conjugated bilirubin into urobilinogen or urobilin, causing faeces to become paler.
Due to bile duct impairment, fats aren’t emulsified & so are excreted. High fat content in faeces.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Wilson’s disease

A

Caused by mutations in ATP7B gene, which prevents incorporation of copper into ceruloplasmin (Rodriguez -Castro et al., 2015).
This leads to accumulation of copper in hepatocytes, which generates oxidative stress and causes cellular damage.
This results in inflammation, necrosis & fibrosis.
This condition can cause acute liver failure when large amounts of copper are released into the blood.

Rodriguez-Castro, K. I., Hevia-Urrutia, F. J., Sturniolo, G. C. (2015) Wilson’s disease: A review of what we have learned. World journal of hepatology, 7(29), 2859–2870.